US firms usually look leaner than their European counterparts when judged by revenue per employee

The company’s shares have nearly halved since the start of the year and expects slower growth this year

Halt to hiring will apply across all markets and departments

Perfection was priced in, anything less provoked panic as shares were hit with worst one-day drop in 25 years

Weight loss comes in at lower end of expectations and triggers stock boost for rival Novo Nordisk

Novo Nordisk has now lost two-thirds of its value in little over a year

Pharma companies also volatile in wake of letters from US president to 17 of them demanding lower prices

Drugmaker Novo Nordisk shares dive amid lower profits

Pharmaceutical giants in Europe brace themselves for a tariffs fight that is likely still to come

Aviation stocks drop amid soaring jet fuel prices in Europe

Iseq index advances 0.5%, dragged higher by Ryanair and the main Irish banks

Parvus shows interest in Danish drugmaker that is hunting for new chief following share price slump

In 2023, Novo Nordisk was suspended by its own industry body in the UK for two years over its sponsorship of weight management courses for health professionals

‘Significant number of non-compliances’ by pharmaceutical firm behind weight loss drugs

Investor expectations, it seems, are harder to manage than blood sugar

Pharmaceutical companies stepped up blitz to push Government to back industry position, lobbying logs show

Danish maker of obesity drugs to replace Lars Fruergaard Jørgensen, saying new leadership is needed

First-quarter sales rise 18 per cent but Danish pharma group blames custom preparations at pharmacies for weaker take-up

Drugmaker has seen shares halved as obesity market heats up

Industry has used trade opportunity to hand European Commission a shopping list of asks